86 related articles for article (PubMed ID: 1569151)
1. Very high concentrations of islet amyloid polypeptide are necessary to alter the insulin response to intravenous glucose in man.
Bretherton-Watt D; Gilbey SG; Ghatei MA; Beacham J; Macrae AD; Bloom SR
J Clin Endocrinol Metab; 1992 May; 74(5):1032-5. PubMed ID: 1569151
[TBL] [Abstract][Full Text] [Related]
2. Elevated islet amyloid pancreatic polypeptide and proinsulin in lean gestational diabetes.
Kautzky-Willer A; Thomaseth K; Ludvik B; Nowotny P; Rabensteiner D; Waldhäusl W; Pacini G; Prager R
Diabetes; 1997 Apr; 46(4):607-14. PubMed ID: 9075800
[TBL] [Abstract][Full Text] [Related]
3. The constitutive secretory pathway is a major route for islet amyloid polypeptide secretion in neonatal but not adult rat islet cells.
Verchere CB; D'Alessio DA; Prigeon RL; Hull RL; Kahn SE
Diabetes; 2000 Sep; 49(9):1477-84. PubMed ID: 10969831
[TBL] [Abstract][Full Text] [Related]
4. Increased plasma levels of islet amyloid polypeptide in patients with primary hyperparathyroidism.
Valdermarsson S; Leckström A; Westermark P; Bergenfelz A
Eur J Endocrinol; 1996 Mar; 134(3):320-5. PubMed ID: 8616529
[TBL] [Abstract][Full Text] [Related]
5. Chronic low dose islet amyloid polypeptide infusion reduces food intake, but does not influence glucose metabolism, in unrestrained conscious rats: studies using a novel aortic catheterization technique.
Arnelo U; Permert J; Larsson J; Reidelberger RD; Arnelo C; Adrian TE
Endocrinology; 1997 Oct; 138(10):4081-5. PubMed ID: 9322915
[TBL] [Abstract][Full Text] [Related]
6. Islet amyloid polypeptide response to glucose, insulin, and somatostatin analogue administration.
Mitsukawa T; Takemura J; Asai J; Nakazato M; Kangawa K; Matsuo H; Matsukura S
Diabetes; 1990 May; 39(5):639-42. PubMed ID: 1970540
[TBL] [Abstract][Full Text] [Related]
7. Islet amyloid polypeptide inhibits insulin secretion in conscious rats.
Fürnsinn C; Leuvenink H; Roden M; Nowotny P; Schneider B; Rohac M; Pieber T; Clodi M; Waldhäusl W
Am J Physiol; 1994 Aug; 267(2 Pt 1):E300-5. PubMed ID: 8074211
[TBL] [Abstract][Full Text] [Related]
8. The effect of different glucose endovenous administrations on amylin and insulin blood concentration in healthy subjects.
Testa I; Ceneralli S; Testa R; Bonfigli AR; Recchioni A; Paoletti P; De Sio G
Boll Soc Ital Biol Sper; 1996; 72(3-4):103-8. PubMed ID: 8771910
[TBL] [Abstract][Full Text] [Related]
9. Transgenic overexpression of human islet amyloid polypeptide inhibits insulin secretion and glucose elimination after gastric glucose gavage in mice.
Ahrén B; Oosterwijk C; Lips CJ; Höppener JW
Diabetologia; 1998 Nov; 41(11):1374-80. PubMed ID: 9833947
[TBL] [Abstract][Full Text] [Related]
10. Failure of islet amyloid polypeptide to inhibit basal and glucose-stimulated insulin secretion in model experiments in mice and rats.
Pettersson M; Ahrén B
Acta Physiol Scand; 1990 Mar; 138(3):389-94. PubMed ID: 2183542
[TBL] [Abstract][Full Text] [Related]
11. Failure to establish islet amyloid polypeptide (amylin) as a circulating beta cell inhibiting hormone in man.
Bretherton-Watt D; Gilbey SG; Ghatei MA; Beacham J; Bloom SR
Diabetologia; 1990 Feb; 33(2):115-7. PubMed ID: 2328845
[TBL] [Abstract][Full Text] [Related]
12. Evidence of cosecretion of islet amyloid polypeptide and insulin by beta-cells.
Kahn SE; D'Alessio DA; Schwartz MW; Fujimoto WY; Ensinck JW; Taborsky GJ; Porte D
Diabetes; 1990 May; 39(5):634-8. PubMed ID: 2185112
[TBL] [Abstract][Full Text] [Related]
13. Lack of effect of islet amyloid polypeptide in causing insulin resistance in conscious dogs during euglycemic clamp studies.
Kassir AA; Upadhyay AK; Lim TJ; Moossa AR; Olefsky JM
Diabetes; 1991 Aug; 40(8):998-1004. PubMed ID: 1860564
[TBL] [Abstract][Full Text] [Related]
14. Increased levels of circulating islet amyloid polypeptide in patients with chronic renal failure have no effect on insulin secretion.
Ludvik B; Clodi M; Kautzky-Willer A; Schuller M; Graf H; Hartter E; Pacini G; Prager R
J Clin Invest; 1994 Nov; 94(5):2045-50. PubMed ID: 7962550
[TBL] [Abstract][Full Text] [Related]
15. Effects of amidated rat islet amyloid polypeptide on glucose-stimulated insulin secretion in vivo and in vitro in rats.
Ar'Rajab A; Ahrén B
Eur J Pharmacol; 1991 Jan; 192(3):443-5. PubMed ID: 2055243
[TBL] [Abstract][Full Text] [Related]
16. Islet amyloid polypeptide in patients with pancreatic cancer and diabetes.
Permert J; Larsson J; Westermark GT; Herrington MK; Christmanson L; Pour PM; Westermark P; Adrian TE
N Engl J Med; 1994 Feb; 330(5):313-8. PubMed ID: 8277951
[TBL] [Abstract][Full Text] [Related]
17. Effects of aging on plasma islet amyloid polypeptide basal level and response to oral glucose load.
Mitsukawa T; Takemura J; Nakazato M; Asai J; Kanagawa K; Matsuo H; Matsukura S
Diabetes Res Clin Pract; 1992 Feb; 15(2):131-4. PubMed ID: 1563328
[TBL] [Abstract][Full Text] [Related]
18. Islet amyloid polypeptide (IAPP) does not inhibit glucose-stimulated insulin secretion from isolated perfused rat pancreas.
O'Brien TD; Westermark P; Johnson KH
Biochem Biophys Res Commun; 1990 Aug; 170(3):1223-8. PubMed ID: 2202297
[TBL] [Abstract][Full Text] [Related]
19. Islet amyloid polypeptide-like immunoreactivity (amylin) in rats treated with dexamethasone and streptozotocin.
Jamal H; Bretherton-Watt D; Suda K; Ghatei MA; Bloom SR
J Endocrinol; 1990 Sep; 126(3):425-9. PubMed ID: 2212934
[TBL] [Abstract][Full Text] [Related]
20. Effect of dexamethasone on insulin sensitivity, islet amyloid polypeptide and insulin secretion in humans.
Ludvik B; Clodi M; Kautzky-Willer A; Capek M; Hartter E; Pacini G; Prager R
Diabetologia; 1993 Jan; 36(1):84-7. PubMed ID: 8436259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
